FDA moves BPC-157 to Category 1 by…?

    Before November

    FDA moves BPC-157 to Category 1 by…?. Best Yes near 37¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 37¢ · Best No: 65¢ · 1 platform

    • Kalshi: Yes 37¢ / No 65¢
    TRADING OPEN

    Before November

    Volume

    $12.2K

    $30 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolved

    ~0 days left

    Category

    Culture

    37¢CHANCE OF YES36%64%
    Yes
    37¢
    Kalshi
    No
    65¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    kalshi
    Kalshi
    Best Yes
    Best No
    Yes
    37¢
    No
    65¢
    Vol
    $12.2K
    $30 24h
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 37¢: exit costs ~1.63¢/contract
    Full calculator

    Market Details

    ResolutionResolved
    Time Left0 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In